Mission: Corporate Lobbying Tracker
Tracking active cases for Corporate Lobbying Tracker.
Big Tech (Google, Meta) Lobbying Spikes Before Antitrust and Regulation Delays
New data from 2025-2026 shows sustained high lobbying by Meta ($26.29M in 2025, $7.1M Q1 2026), Alphabet ($13.1M in 2025, $4.1M Q1 2026) and Amazon ($17.89M in 2025) coinciding with partial antitrust wins for tech firms, ongoing appeals, and scheduled trials. FTC appealed Meta's November 2025 monopoly case dismissal in January 2026; Google received behavioral remedies in search case September 2025 with adtech ruling pending; Amazon trial set for October 2026. Lobbying focuses on AI regulation, privacy and antitrust delays, with Trump administration shifts leading to some enforcement pullbacks but continued court battles.
Regulatory Revolving Door to Corporate Boards and Lobbying
2025 marked record-high lobbying expenditures by the pharmaceutical industry, with PhRMA spending nearly $38 million and total healthcare lobbying surging 16% to $653 million in the first three quarters, underscoring intensified influence amid regulatory shifts. Confirmed reverse revolving door appointments include Chainlink's Taylor Lindman as SEC Crypto Task Force Chief Counsel in February 2026 and Nancy Beck's ongoing senior role at EPA's chemical safety office; former Energy Secretary Jennifer Granholm expanded to Edison International's board alongside her DGA Group position. No major new forward revolving door placements for figures like ex-SEC Chair Gary Gensler as of March 2026, but the pattern persists with legislative efforts like H.R.3554 to curb it.